Biopixlar® - a new paradigm
3D single-cell bioprinting
Biopixlar® represents a new paradigm in bioprinting. The open volume microfluidic technology lets you build functional tissues directly using the cells you want – without the need for any bioink or other carrier material.
Thanks to its high precision cell deposition technology, you can bring your detailed tissue designs to life without having to compromise. Read on to find out how we transform medical research and drug development – cell by cell.
Print any cell
The ability print any cell type with single-cell precision opens up a whole new world of possibilities in everything from fundamental biological research to drug development and regenerative medicine. Biopixlar lets you print even the most demanding cell types in any configuration, from single-cell arrays to organoids and complex tissues. The high precision microfluidic cell deposition technology promotes intercellular communication and ensures high cell viability.
Biopixlar has been used to print hepatocytes, beta cells, cardiomyocytes, T-cells, primary neurons, IPSCs, MSCs, corneal cells, melanoma and adenocarcinoma cells, neuroblastomal cells, fibroblasts, renal epithelial cells, keratinocytes, and much more…
Biopixlar variants
BIOPIXLAR
BIOPIXLAR The original single-cell 3D bioprinter. Using high-performance microfluidic direct cell deposition and with a wide range of add-on options, Biopixlar is a powerful modular research platform capable of producing everything from single cell arrays to organoids and complex tissues.
BIOPIXLAR AER
Powerful and ultra compact. Biopixlar AER is the first single-cell bioprinting platform that fits into a biosafety cabinet and is designed to bring you all the power of Fluicell’s open volume microfluidic bioprinting technology in a streamlined platform built for easy workflow integration.
Biopixlar features
Single-cell resolution
Design biological tissues by printing details down to the level of individual cells.
High-precision and reproducibility
Structure biological tissues by precisely controlling the spatial deposition of your living cells and benefit from high reproducibility across replicates.
>95 % cell viability
The printing process is optimized to minimize the shear forces on the cell sample, achieving very high cell viability (cell viability was tested across multiple cell lines).
Multi-cellular models
Compose your biological tissue by printing up to three different cell types from the same printhead. By changing the printhead, new cell types can be printed.
Real-time monitoring
Follow the printing process in real-time with the fully integrated multi-color fluorescence imaging setup.
Ideal for valuable cell sources
Biopixlar is designed for handling scarce and valuable cell sources such as stem cells, primary cells and patient biopsies.
The BIOPIXLAR advantage
Biopixlar
Extrusion
Stereoelithography
Inkjet
Laser assisted
Printing resolution
+++
+
++++
++
++
Small volume capacity
++++
+
++
+++
+++
Throughput
++
+++
+
++++
+
Fast sample preparation
++++
++
++
+++
+
Large tissue models
+
++++
+++
+
++
No carrier material requirement
++++
+
+
++
+
Cell stress prevention
++++
+
++
+++
+++
Cell on cell printing
++++
+
+
+
+
No need for crosslinking
++++
+
++++
+++
++++
Cell confluency post printing
++++
++
++
+++
++
Cell to non-carrier material interaction
++++
+
+
+++
+
Tissue model cell to cell interaction
++++
+
+
+++
+
what our customers say
Read more
Partnerships
Fluicell’s mission is to transform medicine with next-generation regenerative medicine and screening products. Partner with us to change how we treat diseases.
Pipeline
Our pipeline consists of products based on our tissue production platform, including tissue-based therapeutics for type 1 diabetes treatment, and cardiac toxicity and kidney disease screening models.
Partner with us!
Learn about what we hope to achieve in partnership with innovation-driven pharmaceutical companies. Have questions or interested in exploring a collaboration? Get in touch.